Most people are shocked
EU approval typically follows FDA approval by 36 months
In the case of people who have no influence on the development of the disease from this group, i.e., those with a family history, diabetes, kidney disease, or those who have reached a certain age, therapy can be applied aimed at limiting and alleviating disease symptoms
Enzymes such as Dipeptidyl Peptidase-4 (DPP-4) and Neutral Endopeptidase (NEP) contribute to this process, yielding inactive biological fragments (23)(30) Semaglutide, Serum, and tissue proteases metabolize the polypeptide into amino acids, clearing it from the system and preventing accumulation (23)(21)
And with Eli Lilly's Mounjaro and Zepbound gaining ground, the competitive dynamics between the two pharmaceutical giants will shape pricing and access in the near future
discuss pain management options with your PlexusDx provider before starting therapy